Public signalCompany raiseAuto-indexed · Unverified
Oral Genome Corp. raised $3.1M
Oral Genome Corp.· CARLSBAD, US· Biotechnology· Filed Jan 31, 2025
Oral Genome Corp. reported raising capital. Based in CARLSBAD, CALIFORNIA, US. First sale reported 2025-01-14. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$3.1M
Confidence90%
Raised
$3.1M
Investors
37
Incorporated
2021
Jurisdiction
DELAWARE
On the record
- Location
- CARLSBAD, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $3.1M
- Target amount
- $5.1M
- Filing date
- Jan 31, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2021
- Industry group
- Biotechnology
- Number of investors
- 37
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $5.1M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 3,107,595 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 31, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$1M – $10MCompany Raise
Are you associated with Oral Genome Corp.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record